Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This indicates a minor release of the site template or backend components for the study details page.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.6.2 is now displayed, replacing v3.6.0. This indicates a small maintenance update to the site's version tag used for rendering and change tracking, with no visible impact on study content or navigation.SummaryDifference0.0%

- Check21 days agoChange DetectedThe study record now indicates a Completed status and an expanded network of 49 locations. A new site in Dnipro, Ukraine has been added, and the city name for an existing location has been updated to Kropyvnytskyi (formerly Kirovohrad).SummaryDifference0.5%

- Check28 days agoChange DetectedRecruitment status now indicates enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label and revision note to v3.6.0.SummaryDifference0.3%

- Check36 days agoChange DetectedThe page's Revision label was updated from v3.5.4 to v3.5.5.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision tag was updated to v3.5.4, signaling a new release for the page. There are no detected user-facing content changes associated with this update.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.